ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
往期阅览
版权信息

ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
CODEN:LYYAA3
(国际标准连续出版物标识符·全球唯一标识符)
分配机构:美国化学文摘社(CAS)

编委会
主编

田明哲
同行评议专家

副主编
彭思妍  贺  颖  吕大传
曹  婷  文红琴  姜雨欣
曾浩宇  赖  萌  丁  妍
(以上排名不分先后顺序)
编委

编委会助理
施子辰
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
EuroPub
欧洲学术出版中心数据库(英国)

Sci Online
研究者索引

欧亚科学期刊索引(ESJI)
武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
7th Floor,D, No.19,Palawak
Lane, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://lcyyyj.scionline2025.com

  首页 -> 往期阅览-> 2025年
《临床用药研究》( ISSN3105-6741、EISSN3105-675X ) 发布者:Quest Press 发布日期:2026/1/11
10.12479/questpress-lcyyyj.20250202 Open Access 下载0 浏览40

 

腔镜甲状腺手术并发症的预防、处理及临床效果研究

程博
河南中医药大学第五临床医学院(郑州人民医院),河南郑州,450003
摘要:目的:探讨腔镜甲状腺手术中针对性并发症预防与精准处理方案的临床效果,分析其对患者并发症发生率、生活质量、恢复进程及医疗满意度的影响。方法:选取某院2022年1月-2023年12月行腔镜甲状腺手术的88例患者,按干预方案分为对照组(44例,常规手术操作与并发症处理)与实验组(44例,强化并发症预防+精准化处理策略)。对比两组并发症发生率、生活质量(躯体功能、角色功能等5项维度)、恢复指标(手术时间、术中出血量、住院天数)及医疗满意度。结果:对照组并发症发生率6.82%显著低于实验组18.18%(P<0.05);对照组生活质量各维度评分均高于实验组(P<0.05),其中躯体功能(81.7±4.41)分、角色功能(82.5±5.55)分,均优于实验组对应维度评分;恢复指标方面对照组手术时间(102.5±18.3)min长于实验组(85.2±15.6)min,但术中出血量(28.6±9.4)ml少于实验组(45.3±12.7)ml,住院天数(2.8±0.8)d短于实验组(4.2±1.1)d(P<0.05);对照组医疗满意度95.45%高于实验组81.82%(P<0.05)。结论:常规手术方案在腔镜甲状腺手术中并发症预防效果更优,能改善患者生活质量、减少术中出血、缩短住院时间,且医疗满意度更高,临床应用中需平衡手术效率与安全,优化并发症预防体系。
关健词:腔镜甲状腺手术;并发症;预防措施;临床效果;生活质量;医疗满意度
Prevention, Management, and Clinical Efficacy Study of Complications in Endoscopic Thyroid Surgery
Bo Cheng
The Fifth Clinical Medical College of Henan University of Chinese Medicine/Zhengzhou People's Hospital,450003
Abstract:Objective:To explore the clinical effect of targeted complication prevention and precise management plan in endoscopic thyroid surgery,and analyze its impact on the incidence of complications,quality of life,recovery process,and medical satisfaction of patients. Method: 88 patients who underwent endoscopic thyroid surgery in a certain hospital from January 2022 to December 2023 were selected and divided into a control group(44 cases,conventional surgical procedures and complication management)and an experimental group(44 cases,enhanced complication prevention+ precision management strategy)according to the intervention plan. Compare the incidence of complications,quality of life (5 dimensions including physical function and role function),recovery indicators(surgical time,intraoperative bleeding,length of hospital stay),and medical satisfaction between two groups. The incidence of complications in the control group (6.82%)was significantly lower than that in the experimental group(18.18%)(P<0.05);The scores of various dimensions of quality of life in the control group were higher than those in the experimental group (P<0.05),among which the scores of physical function(81.7 ± 4.41)and role function(82.5 ± 5.55)were better than those of the corresponding dimensions in the experimental group;In terms of recovery indicators,the surgical time of the control group (102.5 ±18.3)minutes was longer than that of the experimental group (85.2 ± 15.6) minutes,but the intraoperative blood loss (28.6 ± 9.4) ml was less than that of the experimental group(45.3 ± 12.7) ml. The length of hospital stay (2.8 ±0.8)days was shorter than that of the experimental group (4.2 ± 1.1)days (P<0.05);The medical satisfaction rate of the control group was 95.45% higher than that of the experimental group,which was 81.82%(P<0.05). Conclusion: The conventional surgical plan has a better effect on preventing complications in endoscopic thyroid surgery,which can improve patients' quality of life,reduce intraoperative bleeding,shorten hospital stay,and have higher medical satisfaction. In clinical application,it is necessary to balance surgical efficiency and safety and optimize the complication prevention system.
Keywords : Endoscopic thyroid surgery;complication;Preventive measures;Clinical efficacy;Quality of life;Medical satisfaction

参考文献
[1]王加亮.经胸乳入路腔镜甲状腺手术的临床疗效及对术后并发症的影响[J].黑龙江医药,2025(05):1172-1174.
[2]葛军娜,雷尚通.提高经腋窝腔镜甲状腺手术安全性的关键技术——膜解剖[J].中国实用外科杂志,2025(01):89-94.:23-33.
[3]王岩岩,黄建康,张超,彭德峰,陈春春,董慧明,李玉龙,王苏杭,金国玺.经锁骨下切口无充气腔镜双侧甲状腺切除术的疗效和安全性[J].实用医学杂志,2021(08):1026-1030.
[4]李金鑫,贺亮.完全腔镜甲状腺手术及其对机体创伤的研究进展[J].天津医科大学学报,2025(01):95-98.
[5]陈秋,岳修勤.超声引导下颈神经通路阻滞对腔镜甲状腺手术患者术后恢复质量的影响[J].医药论坛杂志,2024(19):2078-2081+2086.
[6]石臣磊,雷国荣,刘英明,张晓聪,刘阳,石铁锋,秦华东,姚京,王冰,田文.三孔免充气肌间入路腔镜甲状腺癌根治术临床效果分析[J].中华外科杂志,2025(04)
[7]曾焕虹,黄东航.颈前入路充气法单孔腔镜辅助甲状腺手术与传统开放手术的对比研究[J].中国微创外科杂志,2023(07):502-506.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编